Pre-Conference Planner
This planner lists abstracts in order of presentation, categorized separately by clinical trial and preclinical drug data. We hope you find this pre-conference planner useful and insightful and are as excited as us to see the latest developments in the Adoptive Cell field.
Post-Conference Report
This post-conference report offers a complete guide to all the adoptive cell topics and provides analysis and a summary of abstracts. Most of the presented data at the AACR Annual Meeting showcased preclinical data. Within these abstracts, the established CD19 CAR-T therapies are still the most common modality of choice amongst developers. Find all about them by downloading the report.
More Resources
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
